Teniposide

Chemical formula: C₃₂H₃₂O₁₃S  Molecular mass: 656.654 g/mol  PubChem compound: 452548

Therapeutic indications

Teniposide is indicated for:

Indication

Population group: only adults (18 years old or older)

at least one of
Follicular [nodular] non-Hodgkin's lymphoma
Diffuse non-Hodgkin's lymphoma
Peripheral and cutaneous T-cell lymphomas
Other and unspecified types of non-Hodgkin's lymphoma
Hodgkin's disease
Acute lymphoblastic leukaemia
Acute myeloid leukaemia
Acute promyelocytic leukaemia
Acute myelomonocytic leukaemia
Acute monocytic leukaemia
Acute megakaryoblastic leukaemia
Acute leukaemia of unspecified cell type
Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
Neuroblastoma
Nephroblastoma
Ewing's sarcoma of bone

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: only adults (18 years old or older)

Malignant neoplasm of bladder

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Teniposide is contraindicated in the following cases:

Contraindication

at least one of
Pregnancy
Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈